In this study, we present multi-level evidence demonstrating that key mediators of the TGF-β signaling pathway—SKIL, BMP2, SMAD1, SMAD3, SMAD4, and MAPK1—are consistently upregulated in high-grade astrocytomas. The gene discussed is SMAD3; the disease is astrocytoma (excluding glioblastoma).